Peptide-based cancer therapy: opportunity and challenge

Cancer Lett. 2014 Aug 28;351(1):13-22. doi: 10.1016/j.canlet.2014.05.002. Epub 2014 May 13.

Abstract

Cancer is one of the leading causes of death worldwide. Conventional cancer therapies mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities. Peptides are a novel class of anticancer agents that could specifically target cancer cells with lower toxicity to normal tissues, which will offer new opportunities for cancer prevention and treatment. Anticancer peptides face several therapeutic challenges. In this review, we present the sources and mechanisms of anticancer peptides and further discuss modification strategies to improve the anticancer effects of bioactive peptides.

Keywords: Anticancer mechanism; Cancer therapy; Modification strategy; Peptide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antimicrobial Cationic Peptides / pharmacology
  • Antimicrobial Cationic Peptides / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Molecular Sequence Data
  • Neoplasms / drug therapy*
  • Peptide Library
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Plant Proteins / pharmacology
  • Plant Proteins / therapeutic use

Substances

  • Antimicrobial Cationic Peptides
  • Antineoplastic Agents
  • Peptide Library
  • Plant Extracts
  • Plant Proteins